Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-02

FDA Approved: ZOLPIDEM TARTRATE SUBLINGUAL — Supplemental Application (ENDO USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application to allow the marketing of zolpidem tartrate sublingual, a sublingual formulation of zolpidem, developed by ENDO USA, Inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate Sublingual (zolpidem tartrate sublingual)

Snippet

SUPPL AP for ZOLPIDEM TARTRATE SUBLINGUAL (ZOLPIDEM TARTRATE SUBLINGUAL)